Flubrotizolam

Flubrotizolam is a substance of the benzodiazepine class, a derivative of thienotriazolodiazepine, a structurally fluorinated analog of brotizolam. It has more potent sedative and anxiolytic effects.

Chemistry
Flubrotizolam is a fluorinated metabolite of brotizolam.

Pharmacology
Flubrotizolam is a designer substance and its toxicological and pharmacological properties have not been fully studied, all the information presented is based on observation during the study and testing of the substance on mice.
This substance actively affects GABA receptors, which is the reason for its strong sedative effect. Flubrotizolam acts as a sedative, anxiolytic, antidepressant. Side effects: may cause decreased libido, lethargy, irritability when the drug is discontinued.

Legal status
Germany : NpSG, Industrial and scientific use only,
UK : Under Psychoactive Substances Act.

Technical Information:

Product Name: Flubrotizolam
Other Name(s): FANAX
IUPAC Name: 4-bromo-7-(2-fluorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
CAS: 57801-95-3
Molar Mass: 377.2 g/mol
Molecular Formula: C15H10BrFN4S
InChi Code: InChI=1S/C15H10BrFN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3
InChIKey: VOZDBDBHBXLWCG-UHFFFAOYSA-N
Canonical SMILES: CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4F
Formulation: A crystalline solid